ArticleTransgenic research2008
Resistance of transgenic tobacco plants incorporating the putative 57-kDa polymerase read-through gene of Tobacco rattle virus against rub-inoculated and nematode-transmitted virus.
Article in Transgenic research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Construction and Biological Characterization of Papaya Leaf Curl Guangdong Virus Infectious cDNA Clone.Microbial biotechnology · 2026Article
- Multiple integrations of a sense transgene, including a tandem inverted repeat confer stable RNA-silencing mediated virus resistance under different abiotic and biotic conditions.Transgenic research · 2023Article
- Interplays between Soil-Borne Plant Viruses and RNA Silencing-Mediated Antiviral Defense in Roots.Frontiers in microbiology · 2016Review
- Tobraviruses--plant pathogens and tools for biotechnology.Molecular plant pathology · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotiana tabacum plants were transformed with the 57-kDa read-through domain of the replicase gene of Tobacco rattle virus (TRV) isolate SYM. From a total of six lines containing the viral transgene, four displayed various levels of resistance to TRV infection. Transgenic plants from line 81G were highly resistant to foliar rub-inoculation with the homologous isolate, or with isolates TRV-PpK20 and TRV-PLB, which are almost identical to TRV-SYM in RNA1 sequence. Moreover, 81G plants were moderately resistant to the serologically and genetically distinct, highly pathogenic isolate TRV-GR. Resistance characteristics of line 81G remained stable over six generations. No unambiguous correlation was established between number of transgene insertion loci and level of resistance. Transgene-specific mRNA was clearly detected in plants from susceptible lines but only at an early developmental stage in resistant plants, indicating the operation of a RNA silencing resistance mechanism. Following challenge using viruliferous vector nematodes carrying TRV-PpK20 or by rub inoculation of roots, 81G plants did not show any symptoms and virus was not detected in leaves. However, virus was detected in roots but without apparent effects on plant growth and often at low concentration. When challenged with nematodes carrying TRV-GR, symptoms in aerial parts of 81G plants were less severe and much delayed compared to non-transgenic plants, although younger plants showed less resistance than older ones. No difference was detected in transgene transcript accumulation between leaves and roots of 81G plants. This is the first work reporting a broad level of pathogen derived resistance against two geographically and genetically distinct TRV isolates transmitted directly by their nematode vectors and provides further insight into the expression of transgenic resistance against naturally transmitted soil-borne viruses.
Indexed as
Identifiers
18306053What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.